Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
Tóm tắt
Immunotherapy represents the future of clinical cancer treatment. The type of cancer cell death determines the antitumor immune response and thereby contributes to the efficacy of anticancer therapy and long-term survival of patients. Induction of immunogenic apoptosis or necroptosis in cancer cells does activate antitumor immunity, but resistance to these cell death modalities is common. Therefore, it is of great importance to find other ways to kill tumor cells. Recently, ferroptosis has been identified as a novel, iron-dependent form of regulated cell death but whether ferroptotic cancer cells are immunogenic is unknown.
Ferroptotic cell death in murine fibrosarcoma MCA205 or glioma GL261 cells was induced by RAS-selective lethal 3 and ferroptosis was analyzed by flow cytometry, atomic force and confocal microscopy. ATP and high-mobility group box 1 (HMGB1) release were detected by luminescence and ELISA assays, respectively. Immunogenicity in vitro was analyzed by coculturing of ferroptotic cancer cells with bone-marrow derived dendritic cells (BMDCs) and rate of phagocytosis and activation/maturation of BMDCs (CD11c+CD86+, CD11c+CD40+, CD11c+MHCII+, IL-6, RNAseq analysis). The tumor prophylactic vaccination model in immune-competent and immune compromised (Rag-2−/−) mice was used to analyze ferroptosis immunogenicity.
Ferroptosis can be induced in cancer cells by inhibition of glutathione peroxidase 4, as evidenced by confocal and atomic force microscopy and inhibitors’ analysis. We demonstrate for the first time that ferroptosis is immunogenic in vitro and in vivo. Early, but not late, ferroptotic cells promote the phenotypic maturation of BMDCs and elicit a vaccination-like effect in immune-competent mice but not in Rag-2−/− mice, suggesting that the mechanism of immunogenicity is very tightly regulated by the adaptive immune system and is time dependent. Also, ATP and HMGB1, the best-characterized damage-associated molecular patterns involved in immunogenic cell death, have proven to be passively released along the timeline of ferroptosis and act as immunogenic signal associated with the immunogenicity of early ferroptotic cancer cells.
These results pave the way for the development of new therapeutic strategies for cancers based on induction of ferroptosis, and thus broadens the current concept of immunogenic cell death and opens the door for the development of new strategies in cancer immunotherapy.
Từ khóa
Tài liệu tham khảo
Goldberg, 2019, Improving cancer immunotherapy through nanotechnology, Nat Rev Cancer, 19, 587, 10.1038/s41568-019-0186-9
Mishchenko, 2019, An emerging role for nanomaterials in increasing immunogenicity of cancer cell death, Biochim Biophys Acta Rev Cancer, 1871, 99, 10.1016/j.bbcan.2018.11.004
Zhou, 2019, Immunogenic cell death in cancer therapy: present and emerging inducers, J Cell Mol Med, 23, 4854, 10.1111/jcmm.14356
Vandenabeele P , Vandecasteele K , Bachert C . Immunogenic apoptotic cell death and anticancer immunity. Springer, Cham, 2016: 133–49.
Aaes, 2016, Vaccination with Necroptotic cancer cells induces efficient anti-tumor immunity, Cell Rep, 15, 274, 10.1016/j.celrep.2016.03.037
Krysko, 2017, Necroptotic cell death in anti-cancer therapy, Immunol Rev, 280, 207, 10.1111/imr.12583
Wang, 2018, Pkm2 inhibitor shikonin overcomes the cisplatin resistance in bladder cancer by inducing necroptosis, Int J Biol Sci, 14, 1883, 10.7150/ijbs.27854
Li, 2020, Ferroptosis: past, present and future, Cell Death Dis, 11, 1
Demuynck, 2020, A 3D cell death assay to quantitatively determine ferroptosis in spheroids, Cells, 9, 703, 10.3390/cells9030703
Garg, 2016, Extracellular ATP and P₂X₇ receptor exert context-specific immunogenic effects after immunogenic cancer cell death, Cell Death Dis, 7, 10.1038/cddis.2015.411
Van der Meeren L , Verduijn JM , Krysko DV , et al . Nano-mechanics and topography of regulated cell death by atomic force microscopy. iScience 2020.
Grootjans, 2016, A real-time fluorometric method for the simultaneous detection of cell death type and rate, Nat Protoc, 11, 1444, 10.1038/nprot.2016.085
Klöditz, 2019, Three cell deaths and a funeral: macrophage clearance of cells undergoing distinct modes of cell death, Cell Death Discov, 5, 65, 10.1038/s41420-019-0146-x
Gamrekelashvili, 2012, Primary sterile necrotic cells fail to cross-prime CD8(+) T cells, Oncoimmunology, 1, 1017, 10.4161/onci.21098
Garg, 2015, Molecular and translational classifications of DAMPs in immunogenic cell death, Front Immunol, 6, 10.3389/fimmu.2015.00588
Gong, 2019, The role of necroptosis in cancer biology and therapy, Mol Cancer, 18, 10.1186/s12943-019-1029-8
Shlomovitz, 2019, Flipping the dogma – phosphatidylserine in non-apoptotic cell death, Cell Communication and Signaling, 17, 1, 10.1186/s12964-019-0437-0
Bajor, 2011, Modulatory role of calreticulin as chaperokine for dendritic cell-based immunotherapy, Clin Exp Immunol, 165, 220, 10.1111/j.1365-2249.2011.04423.x
Osman, 2017, Calreticulin release at an early stage of death modulates the clearance by macrophages of apoptotic cells, Front Immunol, 8, 10.3389/fimmu.2017.01034
Zhang, 2019, Resveratrol induces immunogenic cell death of human and murine ovarian carcinoma cells, Infect Agent Cancer, 14, 10.1186/s13027-019-0247-4
Melis, 2013, Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response, Cell Death Differ, 20, 765, 10.1038/cdd.2013.8
Wen, 2019, The release and activity of HMGB1 in ferroptosis, Biochem Biophys Res Commun, 510, 278, 10.1016/j.bbrc.2019.01.090
Wang, 2019, Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress, Mol Med Rep, 20, 4081
Yuan, 2019, Naphthyl quinoxaline thymidine conjugate is a potent anticancer agent post UVA activation and elicits marked inhibition of tumor growth through vaccination, Eur J Med Chem, 171, 255, 10.1016/j.ejmech.2019.03.051